02-03 July 2019
Boston, MA, USA



The Neuropsychiatric Drug Development Summit is industry’s first dedicated discussion and networking forum  with a specific focus on bringing together the leading drug developers to share the latest scientific progress and address the current challenges.

Its mission: to enable drug developers to solve the challenges in bringing  next-generation neuropsychiatric therapeutics to market.

Attend this focussed summit to learn from the field’s pioneers who’ll be sharing their experience and advances in:

  • Comparing methods for improving clinical trial design by understanding the risks and the importance of reaching meaningful endpoints
  • Evaluating pre-clinical models and biomarkers to show necessary efficacy of next generation NDD therapeutics.
  • Identifying novel mechanisms of action for improved patient response